Texas Radiotherapy has expanded its medical services by launching Breast Associates of Texas, a new medical group specializing in breast surgical oncology. The group will be led by Dr. Amelia Tower, an experienced surgeon with over 11 years of practice in Fort Worth. Dr. Tower brings significant expertise to the new medical group, having completed her general surgery residency at Plaza Medical Center and a fellowship in breast surgical oncology from Allegheny General Hospital in Pittsburgh. Additionally, she serves as an Assistant Dean and Associate Professor of Medical Education at Texas A&M College of Medicine.
Dr. Matthew Cavey, radiation oncologist and president of Texas Radiotherapy, emphasized the organization's commitment to patient-centered care. He highlighted Dr. Tower's leadership and expertise as a key asset to the new medical group. Sara Cavey, director of operations, noted Dr. Tower's reputation for treating patients with personalized, family-like care. Her approach aligns closely with Texas Radiotherapy's patient-first philosophy. Dr. Tower expressed her dedication to meeting patients' medical needs and providing comprehensive support throughout their healthcare journey. Her expertise includes specialized techniques like Hidden Scar™, which aims to minimize surgical scarring and facilitate patient recovery.
The expansion of Texas Radiotherapy's services through Breast Associates of Texas represents a significant enhancement in local cancer treatment options. By combining advanced radiation therapies with specialized surgical expertise, the organization continues to improve clinical outcomes and patient experiences in cancer care. This development matters because it addresses a critical need for integrated cancer treatment, where surgical and radiation oncology services work in close coordination. The implications include potentially better treatment outcomes through multidisciplinary care, reduced patient stress from coordinating between different providers, and access to advanced surgical techniques that prioritize both medical effectiveness and cosmetic results.
For patients in the region, this expansion means more comprehensive care under one organizational umbrella, potentially streamlining the often complex journey through cancer diagnosis, treatment, and recovery. The specialized focus on breast surgical oncology within a broader cancer treatment framework represents a model that could influence how cancer care is delivered more broadly. The leadership of an experienced surgeon like Dr. Tower, who also holds academic positions at institutions like Texas A&M College of Medicine, suggests a commitment to both clinical excellence and medical education. This expansion reinforces the trend toward more personalized, patient-centered cancer care that addresses both medical and quality-of-life concerns.
